I.P.A.S. Institute for Pharmacokinetic and Analytical Studies

I.P.A.S. Institute for Pharmacokinetic and Analytical Studies was a Swiss contract research and analytical services company focused on pharmacokinetic, bioavailability, bioequivalence, tolerability, and Phase 1 clinical studies. The company also performed chemical, clinical, environmental, and food analyses, with capabilities spanning chromatographic bioanalysis and related laboratory testing. Historical descriptions indicate that IPAS primarily supported generic drug development through bioequivalence work rather than building a proprietary therapeutic pipeline. Corporate registry sources indicate the company entered liquidation and was deleted from the commercial register in April 2014 following closure of bankruptcy proceedings.